Ocugen, Inc. - OCGN

SEC FilingsOur OCGN Tweets

About Gravity Analytica

Recent News

  • 06.11.2025 - Ocugen To Present at BIO International Convention 2025
  • 06.11.2025 - Ocugen To Present at BIO International Convention 2025
  • 06.11.2025 - Ocugen To Present at BIO International Convention 2025
  • 06.09.2025 - Boris Peaker Ph.D. CFA
  • 06.09.2025 - Boris Peaker Ph.D. CFA
  • 06.06.2025 - Blaise Coleman, MBA
  • 06.06.2025 - Blaise Coleman, MBA
  • 06.06.2025 - Satish Chandran, PhD
  • 06.06.2025 - Satish Chandran, PhD
  • 06.05.2025 - Ocugen, Inc. Announces Signing of Binding Term Sheet for the License of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea

Recent Filings

  • 06.11.2025 - 144 Report of proposed sale of securities
  • 06.09.2025 - 4 Statement of changes in beneficial ownership of securities
  • 06.09.2025 - 4 Statement of changes in beneficial ownership of securities
  • 06.09.2025 - 3 Initial statement of beneficial ownership of securities
  • 06.09.2025 - 4 Statement of changes in beneficial ownership of securities
  • 06.09.2025 - 3 Initial statement of beneficial ownership of securities
  • 06.09.2025 - 4 Statement of changes in beneficial ownership of securities
  • 06.09.2025 - 4 Statement of changes in beneficial ownership of securities